MedTrace Logo

Comparison of Biomatrix and Orsiro Drug Eluting Stent

NCT02299011 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 2341

Last updated 2019-09-25

No results posted yet for this study

Summary

The primary objective of the BIODEGRADE study is to evaluate clinical efficacy of the Orsiro drug-eluting stent compared with Biomatrix drug-eluting stent, both of which have biodegradable polymer for the treatment of all-comers' coronary artery diseases.

Conditions

Interventions

DEVICE

Orsiro drug eluting stent

Orsiro Hybrid drug eluting stent

DRUG

Biomatrix drug eluting stent

Biomatrix Flex drug eluting stent

Sponsors & Collaborators

  • Wonju Severance Christian Hospital

    collaborator OTHER

  • Korea University Guro Hospital

    collaborator OTHER

  • Gangnam Severance Hospital

    collaborator OTHER

  • Chungnam National University Hospital

    collaborator OTHER

  • The Catholic University of Korea

    collaborator OTHER

  • Korea University Anam Hospital

    collaborator OTHER

  • Kosin University Gospel Hospital

    collaborator OTHER

  • KangWon National University Hospital

    collaborator OTHER

  • Gachon University Gil Medical Center

    collaborator OTHER

  • Seoul National University Bundang Hospital

    lead OTHER

Principal Investigators

  • In-Ho Chae, MD · Seoul National University Bundang Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2019-06-30
Completion
2019-09-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02299011 on ClinicalTrials.gov